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Este trabalho descreve um método para a determinação quantitativa de ácido acetilsalicílico
(ASA) utilizando procedimento “spot test” e reflectância difusa. O método é baseado na formação do
complexo de cor roxa intensa entre o ácido salicílico, obtido a partir da hidrólise alcalina do ASA, e
íons Fe(III). O procedimento proposto permite a análise de medicamentos contendo ASA de forma
fácil e simples, uma vez que não é necessário fazer separações. A reflectância da mistura final,
colocada sobre um disco de papel de filtro, é medida diretamente. Foram analisados nove medicamentos
comerciais contendo ASA cujos resultados apresentaram um desvio padrão relativo médio de 0,9%.
O limite para a determinação quantitativa é de 0,6 mg de ASA na solução de trabalho. As análises
feitas com o método proposto foram comparadas com outras análises, das mesmas amostras, segundo
o procedimento recomendado pela “United States Pharmacopoeia”, onde se observou um desvio
padrão relativo de 0,6%. Compararam-se os dois métodos utilizando-se o teste t de Student. Para um
grau de liberdade ν = 4 (ν = n1 + n2 – 2) e um limite de confiança α = 0.05, onde t = 2,78, todos os
resultados foram concordantes.
This paper describes a quantitative reflectance spot test procedure for the determination of
acetylsalicylic acid (ASA) in pharmaceutical preparations. The method is based on the reaction of
salicylic acid, obtained from the hydrolysis of ASA, with Fe(III) forming a deep blue-violet compound.
Medicines containing ASA can be easily analyzed by the proposed method as it is not necessary to
do any separation. The final mixture is placed on a sheet of filter paper, and the reflectance is directly
measured. Nine commercial medicines containing acetylsalicylic acid were analyzed with the proposed
method. The mean RSD was 0.9%. Results were compared with those obtained with the United
States Pharmacopoeia recommended procedure (RSD 0.6%). The quantitative detection limit is 0.6
mg ASA in the working solution. For a degree of freedom ν = 4 (ν = n1+ n2 – 2) and a confidence
coefficient α = 0.05 all the results agree under the tabulated t-Student test value (2.78).
Keywords: acetylsalicylic acid, spot test, quantitative analysis, reflectance, pharmaceutical
preparations
Introduction
Acetylsalicylic acid (ASA) is a remedy with anti-
inflammatory, analgesic and anti-pyretic properties. It was
synthesized in 1897 in a pure and stable form, by Dr. Felix
Hoffmann, in the laboratories of the “Farbenfabrik
Freidrich Bayer”, in Elberfeld, Germany. It was introduced
in the medical clinic two years later with the name “aspirin”,
i.e., “a” from acetyl and “spir” from the family plants Spirea
that contains derivatives of the salicylic acid.1
The anti-pyretic and analgesic efficiency of ASA was
promptly comproved, however only after the years 1940 it
began to be employed in higher doses as anti-inflammatory.
When its mechanism of action began to be understood2
the possibility for use against cardiac and circulatory
disturbs became evident.3
The consumption of ASA is always increasing and
corresponds to several tons per year. For instance, in 1997
it was claimed that it could to be as high as 20 000 tons
only in the United States.4
ASA is one of the oldest medicines that yet plays an
important role in the modern therapeutics. The main
metabolite of the ASA is the salicylic acid that results from
its hydrolysis and can be qualitatively determined giving
indirectly the quantity of the former. The determination of
ASA in pharmaceutical preparations is important for
assessment of their quality and, in blood serum, to control
therapies based on this compound and for toxicological
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procedures. Intoxication accidents with children, for
instance, are not rare due to the accessibility of this drug.5
The acid-base titration,6 as well as the spectrophoto-
metric methods exploiting Trinder’s reaction7, are based
on the hydrolysis of the acetylsalicylic acid. Trinder’s
procedure involves the formation of a deep blue-violet
complex formed between salicylic acid and Fe(III). Some
spectrophotometric flow injection methods, using on line
hydrolysis, have been developed.8
Ultra-violet,9 fluorescence10 and infra-red11 spectropho-
tometric methods have been also described for the
determination of ASA and salicylic acid in pharmaceutical
preparations. However it seems that they are not frequently
used, possibly due the difficult and tedious preparations
of the samples. Chromatographic procedures are also used,
mainly HPLC.12 Methods using atomic absorption
spectrometry have been also applied.13 These methods,
however, involve expensive apparatus and usually need
extraction procedures.
Ion selective electrodes have been developed showing
high specificity, good detection limits and relatively low
cost.14-17
Biosensors and bioreactors based on the enzyme
salicylate hydroxylase have been also employed. They
are highly specific and can detect very low concentrations.
Despite the high price of the enzyme, they can be anchored
on a fixed support and be used several times, thus decreasing
the cost per analysis.18-20
The analysis of pharmaceutical preparations has as
objective not only the industrial quality control but also
the idoneousness of the product. Recently, in Brazil, a
number of medicines were falsified, from antipyretic to
contraceptives, antibiotics, anti-cancerigenous etc. with
serious consequences. In order to restrain facts like these,
it is important to develop rapid, low cost and simple
analytical procedures, which can be used without
sophisticated apparatus, in locus, yielding reliable results.
In this aspect, spot test procedures can be a very good
alternative. This kind of methods has been currently used,
for example, for the qualitative detection of intoxications
in biological fluids, as blood and urine.21
The visual qualitative spot test is based on a change of
color when a chemical reaction between the analyte and
the utilized reagent takes place. This color change is
proportional to the analyte concentration, therefore
quantitative spot test procedures can be envisaged. In this
paper, the concentrations of ASA in several commercial
pharmaceutical preparations were determined, using a
reflectance procedure based on the reaction of the salicylic
acid with Fe(III) forming a deep blue-violet compound.
A very simple homemade reflectometer was used. The
apparatus is essentially composed by a light emitter diode
(LED) and a light dependent resistor (LDR).22
Experimental
Reagents and solutions
All reagents used were of analytical grade quality. The
water used to prepare the solutions was first distilled in a
glass distiller and then passed through a Milli QPlus
deionizer. The solutions were prepared as follows.
Sodium hydroxide solution (0.5 mol L-1). 2.0 g NaOH
were dissolved in water and diluted to 100 mL.
Nitric acid solution (1.0 mol L-1). 62.5 mL of
concentrated nitric acid were diluted to 1.0 L with water.
Iron III solution. 9.35 g Fe(NO3)3.9H2O were dissolved
in 100.0 mL of water.
Analytical curve
The analytical curve was obtained in the same way as
described in the procedure bellow, using six different
aliquots containing 0.0, 1.2, 3.0, 5.1, 10.0 and 13.2 mg
ASA. The filter paper used as support for the spot was
considered as the blank. Three reflectance measurements
were performed for each aliquot and also for the blank,
and the mean value was considered.
Analytical procedure
Dissolve carefully an aliquot of the pharmaceutical
preparation, containing about 10 mg ASA, in 1.00 mL of
an aqueous solution of NaOH 0.5 mol L-1. Then add 1.00
mL of HNO3 1.0 mol L-1solution. The pH of this final
solution should be about 2.5. Add 2 drops (about 0.10 mL)
of the Fe(III) solution. A deep blue-violet color is
developed. Place two drops of this solution on a filter paper.
A spot with about 3 cm in diameter is formed. Perform
reflectance measurements directly on the spot.
Results and Discussion
The analytical curve is a straight line. Resistance values
of the light dependent resistor are linearly related to the
acetylsalicylic acid contents of the aliquot from 0 up to
13.2 mg. Beyond this amount of ASA, formation of a blue
precipitate is observed and the measured resistance values
deviate form the straight line.
The analytical curve is described by the equation
R = 246 + 10.7 × CASA, where R is the measured resistance,
in kohm, and CASA is the ASA contents of the aliquot,
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in mg. The observed correlation coefficient is 0.997
(n = 6).
The detection limit is about 0.6 mg ASA in the working
solution described above in the analytical procedure.
However, even in medicines containing low ASA quantities
is always possible to weight a portion in order to obtain an
amount of about 10 mg. Therefore, the quantitative
detection limit can be easily improved.
Table 1 shows the acetylsalicylic acid concentration
of nine samples, analyzed by the United States
Pharmacopoeia method and by the proposed procedure.
Three aliquots were used for each sample. The statistical
t-Student test was applied to compare the results obtained
by the two analytical methods.23 Considering that for the
degree of freedom (ν) 4 the tabulated t value is 2.78 (α =
0.05), no significant differences were observed between
the results obtained by the two methods at the 95%
confidence level. The medicine samples were purchased
in the local market. All contain starch and/or lactose. Some
contain dyes, flavors and other compounds. In this case
additional informations are introduced in Table 1. The
experimental results are shown normalized to 100.0% as
the analyzed medicines contained different nominal
quantities of ASA, from 100 mg to 500 mg per tablet.
Normalization allows better comparison of the results
obtained with the nine medicines independently of the
ASA content. Also, in this manner, the relative confron-
tation of the ASA nominal content of the analyzed
medicines is easily done.
The analytical results obtained with this method
should be understood as the total content of salicylic acid
plus ASA, in the medicine, likewise the pharmacopoeia
method that does not discriminate the two substances, as
the actual pharmaceutical active substance is the salicylate
to which ASA is hydrolyzed in the body.
If desired, to test if there is significant quantity of
salicylic acid present in the medicine, the Trinder reaction
can be performed before the alkaline hydrolysis. In this
work development of blue color was not visually observed
when the Fe(III) was added to the acidified non hydrolyzed
solutions of the nine medicines.
Considering the obtained results, the method proposed
in this work can be recommended for the determination of
ASA in pharmaceutical preparations.
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